BiotechTube
Home/Fortitude Biomedicines/Keith Dewedoff
KD

Keith Dewedoff

Acting Chief Financial Officer

Fortitude Biomedicines

Roles

Acting Chief Financial OfficeratFortitude Biomedicines
Chief Financial OfficeratSpyBiotech

Therapeutic Areas

Autoimmune DiseasesOncology

Fortitude Biomedicines Pipeline

DrugIndicationPhase
Lead Immune Cell Targeting ProgramAutoimmune Disease (Undisclosed)Preclinical
GLUE-DAC™ Platform PipelineOncology & Autoimmune DiseasesDiscovery/Preclinical

Leadership Team at Fortitude Biomedicines

SM
Stephen Monks, Ph.D.
Acting Chief Development Officer
JT
Jan Theunissen, Ph.D.
Vice President, Discovery
HL
Haibo Liu, Ph.D.
Director, Medicinal Chemistry
MH
Matthew Huggins, Ph.D.
Principal Scientist, Immunology
WN
Wendi Ni
Director, Operations and Corporate Development
View full Fortitude Biomedicines profile